Colon Cancer Clinical Trial

Self-monitoring and Reminder Texts to Increase Physical Activity After Cancer: a Pilot Randomized Controlled Trial

Summary

Epidemiologic data consistently indicate that colorectal cancer survivors can improve their quality-of-life and prognosis by engaging in physical activity. This study aims to build on this epidemiologic work and translate the findings to inform and change patient behavior. The specific aims are to: (1) Develop a mobile technology physical activity intervention among colorectal cancer patients who have completed therapy. (2) Conduct a 3-month pilot randomized controlled trial utilizing mobile technology to increase physical activity among 40 men and women who have completed standard cytotoxic chemotherapy for primary stage I-III colorectal cancer at the UCSF Helen Diller Family Comprehensive Cancer Center. Participants in the intervention arm will receive a Fitbit® for self-monitoring, interactive text messages, and educational print materials; participants in the control arm will receive educational print materials at baseline and will be given a Fitbit® after completion of the 3-mo. follow-up assessment.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

stage I-III colon or rectal adenocarcinoma
completed standard cytotoxic chemotherapy if medically indicated
be considered disease-free at baseline
be able to speak and read English
have no contra-indication to moderate to vigorous aerobic exercise
be able to walk unassisted
be inactive at baseline (<150 min/week of moderate physical activity)
have access to a mobile phone
be able to navigate websites, fill out forms on the web, communicate by email, and have regular access to the internet

Study is for people with:

Colon Cancer

Estimated Enrollment:

42

Study ID:

NCT02966054

Recruitment Status:

Completed

Sponsor:

University of California, San Francisco

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

University of California, San Francisco
San Francisco California, 94158, United States

How clear is this clinincal trial information?

Study is for people with:

Colon Cancer

Estimated Enrollment:

42

Study ID:

NCT02966054

Recruitment Status:

Completed

Sponsor:


University of California, San Francisco

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider